Diagnostic and Biotech

Malaysia Intravenous Immunoglobulin (IVIG) Market by Product Types (IgG, IgA, IgM, IgE and IgD), Application (Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy, Immunodeficiency Diseases, Myasthenia Gravis, Multifocal Motor Neuropathy, Primary Immune Thrombocytopenic Purpura, Inflammatory Myopathies, Specific Antibody Deficiency, Guillain-Barré Syndrome, Kawasaki Disease, Secondary Immune Deficiency, And Other Applications), Mode of Delivery (Intravenous, Intramuscular, Subcutaneous), and Concentration (5%, 10% and Other Concentration): Opportunity Analysis and Industry Forecast, 2014-2022

  • ALL1194838
  • 164 Pages
  • May 2017
  • Diagnostic and Biotech

Intravenous immunoglobulin (IVIG) is a blood/plasma product, which is prepared from the serum of multiple of donors, used to treat patients with antibody deficiency. The isolated plasma product is clinically treated and purified to Ig, which further facilitates the treatment. IVIG is applicable in various fields such as hematology, immunology, neurology, dermatology, nephrology, ophthalmology, and rheumatology.

The Malaysia IVIG market was valued at $12,277 thousand in 2015, and is projected to reach $18,649 thousand by 2022, registering a CAGR of 6.1% during the forecast period. This is attributed to increase in prevalence of chronic inflammatory demyelinating polyneuropathy (CIDP) & hypogammaglobulinemia and rise in use of immunoglobulins to treat Guillain-Barre syndrome (GBS), inflammatory myopathies, specific antibody deficiency, and others. Increase in geriatric population & number of hemophilic patients, improved IVIG production owing to the emergence of advanced technologies, and enhanced purification techniques (with better plasma yield) drive the growth of the market. However, stringent government regulations toward IVIG products, expensive therapy, and high risk of side effects associated with the use of IVIG are expected to hamper the market growth.

The report segments the Malaysia IVIG market based on application, product type, mode of delivery, and concentration by both- value and volume. Applications covered in the study include hypogammaglobulinemia, CIDP, immunodeficiency diseases, myasthenia gravis, multifocal motor neuropathy, idiopathic thrombocytopenic purpura (ITP), inflammatory myopathies, specific antibody deficiency, GBS, Kawasaki disease, secondary immune deficiency disease, and others.

Hypogammaglobulinemia and CIDP held dominant market shares in 2015 due to the large patient population and unavailability of effective alternatives to IVIG treatment. Based on product type, the market is segmented into immunoglobulin G (IgG), IgA, IgM, IgE, and IgD. By mode of delivery, it is bifurcated into intravenous, subcutaneous, and intramuscular. On the basis of concentration, it is categorized into 5%, 10%, and others. The intravenous mode of delivery segment held the largest revenue share in 2015, and is anticipated to continue this trend during the forecast period.


  • Grifols S.A.,
  • Octapharma AG
  • Green Cross Corporation
  • Baxalta (Shire)
  • Bio Products Laboratory Ltd.
  • Biotest AG,
  • CSL Behring
  • Omrix Biopharmaceuticals Ltd.
  • Bayer Healthcare
  • Baxter International Inc.


  • The study provides an in-depth analysis of the Malaysia IVIG market and the current trends and future estimations to elucidate the imminent investment pockets.
  • The report presents quantitative analysis of the market from 2014 to 2022 to enable stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the market based on applications assists to understand the trends in the industry.
  • Key market players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.


By Application

  • Hypogammaglobulinemia
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
  • Immunodeficiency Diseases
  • Myasthenia Gravis
  • Multifocal Motor Neuropathy
  • Idiopathic Thrombocytopenic Purpura (ITP)
  • Inflammatory Myopathies
  • Specific Antibody Deficiency
  • Guillain-Barré Syndrome
  • Kawasaki Disease
  • Secondary Immune Deficiency
  • Others

By Product

  • IgG
  • IgA
  • IgM
  • IgE
  • IgD

By Mode of Delivery

  • Intravenous
  • Intramuscular
  • Subcutaneous

By Concentration

  • 5% Concentration
  • 10% Concentration
  • Other Concentration

The other players in the value chain include (profiles not included in the report)

  • BDI Pharma, Inc.
  • China Biologics Products, Inc.
  • LFB Biotechnologies
  • Hualan Biological Engineering Inc.
  • Guizhou Taibang Biological Products Co., Ltd.
  • Beijing Tiantan Biological Products Co., Ltd.
  • Shanghai Raas Blood Products Co. Ltd.
Please Select Format

Enquiry About Report

Need More Information

Contact us
+ 1-800-910-6452
+91 20 66346066
--- or ---



European NGS Services Market - Opportunities and Forecasts, 2015 - 2020

Next Generation Sequencing (NGS) services, also known as high-throughput sequencing, is term used to describe sequencing technologies, such as Illumina sequencing, Roche 454 sequencing, and SOLiD sequencing. These technologies enable ...

April 2018| $3390 | Pre Book Price:$2967

World Surface Analysis Market - Opportunities and Forecasts, 2014 - 2020

Surface analysis is a technique that provides a medium to correlate performance with thin film conformation. The analysis is used in the discovery of new materials and to enhance the ...

April 2018| $5370 | Pre Book Price:$4699

World Electrophoresis Market - Opportunities and Forecasts, 2015 - 2020

Electrophoresis is a technique used for separation of proteins and nucleic acids. This technique is primarily used for RNA and DNA analysis. It is also used in biochemistry for separation ...

April 2018| $5370 | Pre Book Price:$4699

World Oxidative Stress Assay Market - Opportunities and Forecasts, 2015 - 2020

Oxidative stress assay is used to determine level of oxidative stress markers and reagents in cells. Applications of oxidative stress assay are research laboratories and bioproduction. Assays detect generalized oxidative ...

April 2018| $5370 | Pre Book Price:$4699

European Microscopy Market - Opportunities and Forecasts, 2015 - 2020

Microscopy is a field of science in which objects are not visible to bare eye can be viewed under microscope. It is used to observe macromolecules and macromolecular complexes at ...

April 2018| $3390 | Pre Book Price:$2967

World Immunoassay Market - Opportunities and Forecasts, 2015 - 2020

Immunoassay is a test conducted to determine concentration of macromolecule in a solution using antibody or immunoglobulin. The macromolecule detected is known as analyte. Immunoassay is used to measure quantity ...

April 2018| $5370 | Pre Book Price:$4699

2018 © Copyright Big Market Research

View Pricing >>